Viewing Study NCT03207958


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-03-06 @ 6:19 PM
Study NCT ID: NCT03207958
Status: COMPLETED
Last Update Posted: 2024-03-13
First Post: 2017-06-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Sponsor: Washington University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Vs Host Disease View
None Graft-versus-host-disease View
Keywords: